GSA Capital Partners’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-49,160
| Closed | -$1.84M | – | 1914 |
|
|
2021
Q2 | $1.84M | Buy |
49,160
+39,869
| +429% | +$1.49M | 0.21% | 67 |
|
|
2021
Q1 | $238K | Sell |
9,291
-10,397
| -53% | -$266K | 0.04% | 792 |
|
|
2020
Q4 | $434K | Sell |
19,688
-4,700
| -19% | -$104K | 0.07% | 511 |
|
|
2020
Q3 | $439K | Buy |
+24,388
| New | +$439K | 0.07% | 474 |
|
|
2020
Q2 | – | Sell |
-10,225
| Closed | -$188K | – | 1285 |
|
|
2020
Q1 | $188K | Sell |
10,225
-45,964
| -82% | -$845K | 0.05% | 779 |
|
|
2019
Q4 | $1.24M | Buy |
+56,189
| New | +$1.24M | 0.14% | 120 |
|